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for age and trilostane use, subclinical group was associated with
reduced risk of clinical outcomes (adjusted hazard ratio, 0.28; 95%
confidence interval, 0.10–0.77).
The results of this study suggest that hypercortisolism in dogs
includes subclinical PDH with an older age, lower post-ACTH stimula-
tion cortisol, and lower risk of clinical outcomes compared to
overt PDH.
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Hyperthyroidism is an elderly cats’ frequent disease. Its prevalence
has been increasing worldwide. Many evidences raised regarding
hyperthyroidism risk-factors. By this way, those factors would have
implications in the huge geographic prevalence variation observed.
The objective of this study was to look for potential environmental
variables associated with feline hyperthyroidism around Porto Alegre
city, Southern Brazil. A 30-questions questionnaire was applied to
28 hyperthyroid feline owners as well as to 55 euthyroid (above
8 years of age) feline owners (n:m). Results of univariate analysis were
expressed as odds ratio (OR) and respective 95% confidence interval
(95%IC). Mean age of hyperthyroid cats was 13.2  2.7 years (range:
7-18), while euthyroid cats mean age was 11.6  2.4 years (range:
8-16) (P < 0.01). Age greater than 12 years was considered as a risk-
factor (OR 3.14; 95%CI = 1.10 – 8.97), as well as canned foods expo-
sure (OR 2.87; 95%CI = 1.10 - 7.50) as previously described. Bathing
frequency showed an association between higher bathing frequency
(weekly/monthly) and hyperthyroidism (OR 7.57; 95%CI = 1.41 -
40.55). Other items surveyed, such as the use of plastic accessories,
contact with domestic dust, use of endoparasiticides, ectoparasiti-
cides, and vaccines, it was not possible to identify any association of
these variables as risk or protective factors. Previous data suggest that
bathing could have a protective effect cleaning off dust particles from
the fur. The bath hypothesis as risk-factor needs further studies due
to possible presence of endocrine disruptors linked with thyroid dis-
function in cosmetic products.
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Canine pituitary-dependent hyperadrenocorticism (PDH) is a common
endocrine disorder. Clinical management usually demands lifelong tri-
lostane therapy, which may cause endogenous ACTH (eACTH)
elevation, adrenomegaly, and recurrent dosage adjustments. Selegiline
therapy has been previously indicated for canine PDH treatment at the
pituitary level, but not encouraged. However, there have been no stud-
ies associating trilostane and selegiline for PDH treatment in dogs. The
aim of this work was to evaluate the clinicopathological features, imag-
ing findings, and hormone test results in dogs with PDH treated with
trilostane (Tri) or with trilostane and selegiline (Tri+Sel). Fifteen client-
owned dogs diagnosed with spontaneous PDH were evaluated: eight
were treated with Tri and seven with Tri+Sel in a randomized clinical
trial. Dogs underwent clinical examination, serum biochemical analysis,
urinalysis, abdominal ultrasound, and eACTH and post-ACTH cortisol
measurements on treatment days zero (D0), 30 (D30), 90 (D90), and
180 (D180). Patients included in the Tri group were initially treated
with trilostane at an initial dose of 0.5 mg/kg PO twice daily, whereas
the Tri+Sel group initially received 0.5 mg/kg PO of trilostane twice
daily and 1 mg/kg PO of selegiline once daily. There was no significant
difference at the 95% confidence level in eACTH variation between the
Tri group (median D0 = 20.85 pg/dL; median D180 = 79.0 pg/dL;
p = 0.07) and the Tri+Sel group (median D0 = 103 pg/dL; median
D180 = 98.25; p = 0.57). Both groups showed significant lower post-
ACTH cortisol levels at the end of the study (Tri median D0 = 15 μg/dL;
D180 = 5.2 μg/dL; p = 0.002 vs. Tri+Sel median D0 = 17.23 μg/dL;
D180 = 2.26 μg/dL; p = 0.006). Also, both groups needed trilostane
dosage adjustments (p = 0.01). However, no statistical difference was
observed between the groups at the end of the study regarding eACTH
or post-ACTH cortisol levels. Nonetheless, there was minor variation in
left adrenal gland thickness in the Tri+Sel group (left adrenal median
D0 = 0.65 cm; median D180 = 0.71; p = 0.7) when compared with the
Tri group (left adrenal median D0 = 0.77 cm; median D180 = 0.97 cm;
p = 0.09). The same was observed for right adrenal gland thickness (Tri
+Sel median D0 = 0.65 cm; median D180 = 0.58 cm; p = 0.2 vs. Tri
median D0 = 0.58 cm; median D180 = 0.77 cm; p = 0.04). Moreover,
patients in the Tri+Sel group seemed to have achieved better metabolic
control throughout fructosamine and total cholesterol evaluation. Not-
withstanding, no differences in clinical control or cognitive function sta-
tus were perceived between the groups. The association of selegiline
with trilostane seems to be a safe and promising complementary ther-
apy for canine PDH. However, further studies with a larger sample size
and longer follow-up are needed to clarify the actual effect of this
association.
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Occult urinary tract infection (UTI) is assumed as a common comorbid-
ity in canine patients with hyperadrenocorticism (HAC), affecting up to
50% of cases at initial diagnosis. However, increased concern about
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